Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy
Authors
Keywords
-
Journal
CANCER INVESTIGATION
Volume 40, Issue 1, Pages 26-34
Publisher
Informa UK Limited
Online
2021-10-14
DOI
10.1080/07357907.2021.1992420
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Challenges and Opportunities for COVID-19 Vaccines in Patients with Cancer
- (2021) Nicole M. Kuderer et al. CANCER INVESTIGATION
- Effects of cancer screening restart strategies after COVID-19 disruption
- (2021) Lindy M. Kregting et al. BRITISH JOURNAL OF CANCER
- Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
- (2021) Barliz Waissengrin et al. LANCET ONCOLOGY
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- COVID-19 Vaccines in Patients With Cancer—A Welcome Addition, but There Is Need for Optimization
- (2021) Eleni Korompoki et al. JAMA Oncology
- Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults
- (2021) Nawal Al Kaabi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan
- (2021) Shu Yazaki et al. JAMA Oncology
- Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease
- (2021) Thomas A. Ollila et al. JAMA Oncology
- Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
- (2021) Amir Massarweh et al. JAMA Oncology
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- (2020) Nicole M Kuderer et al. LANCET
- Low prevalence of IgG antibodies to SARS‐CoV ‐2 in cancer patients with COVID ‐19
- (2020) Tao Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- Mortality in hospitalized patients with cancer and coronavirus disease 2019: A systematic review and meta‐analysis of cohort studies
- (2020) Aakash Desai et al. CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started